But the drug maker's revenue gain exceeded market expectations and it gave a solid forecast, lifting its stock. DETAILS: The Silver Spring, Md.-based company paid more to pay its employees in stock because the value of its shares increased. Excluding …
Yahoo New Zealand · 10/29/2013
Health-care stocks haven't had the healthiest year. Patent expirations have hobbled the drug industry. A weak global economy has squeezed health-care spending. And investors remain skittish regarding government scrutiny and reforms here and abroad.
Barron's · ByJohanna Bennett · 2/15/2011
The Post/Bloomberg index fell 3.6 percent. *United Therapeutics (UTHR) was the biggest gainer last week, with shares of the Silver Spring biotech gaining 9 percent, to $102.70. Shares went as high as $106.24 on Thursday, their 52-week high. On Monday ...
The Washington Post · 7/7/2008